Address:
Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110
Room 11409, Mid Campus Center (office)
Admin:
Annalise Seger
segera@wustl.edu
- GI malignancies
- Molecular profiling of GI malignancies and their clinical applications
- Biomarkers discovery and their incorporation in investigator-initiated trials
- Germline pharmacogenomics of DPYD and TYMS genes
- The translational impact of exosomes
Biosketch
Education
- 2006-2000: Bachelor of Medicine and Surgery (MBBS), equivalent to MD degree, The University of Jordan
Post-Graduate Training
- 2015-2012: Hematology-Oncology Fellow, The University of Miami Leonard Miller School of Medicine/JMH, Miami, FL
- 2012-2011: Internal Medicine Chief Resident, Henry Ford Hospital/Wayne State University, Detroit, MI
- 2011-2008: Internal Medicine Resident, Henry Ford Hospital, Detroit, MI
- 2008-2007: Internal Medicine Resident Transitional Year, King Hussein Cancer Center, Amman, Jordan
- 2007-2006: Intern, Jordan University Hospital, Amman, Jordan
Academic Positions & Employment
- present-2022: Associate Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO
- 2022-2021: Associate Professor, Medicine, The University of Alabama at Birmingham/O’Neal CCC, Birmingham, AL
- 2021-2020: Associate Professor, Interdisciplinary Clinical Oncology, The University of South Alabama/Mitchell Cancer Institute, Mobile, AL
- 2020-2015: Assistant Professor, Interdisciplinary Clinical Oncology, The University of South Alabama/Mitchell Cancer Institute, Mobile, AL
Appointments & Committees
- 2022-2021: Chair, Gastrointestinal Oncology Working Group, The University of Alabama at Birmingham/O’Neal CCC, Birmingham, AL
- 2022-2021: Head of Medical Oncology, UAB Pancreatobiliary Disease Center, The University of Alabama at Birmingham/O’Neal CCC, Birmingham, AL
- 2022-2021: Scientist, Experimental Therapeutic Program, The University of Alabama at Birmingham/O’Neal CCC, Birmingham, AL
- 2022-2021: Section Chief, Gastrointestinal Oncology, The University of Alabama at Birmingham/O’Neal CCC, Birmingham, AL
- 2022-2021: Medical Director, O’Neal Clinical Trials Office, The University of Alabama at Birmingham/O’Neal CCC, Birmingham, AL
- 2021-2019: Leader, Gastrointestinal Oncology Program, The University of South Alabama/Mitchell Cancer Institute, Mobile, AL
- 2021-2019: Director, Medical Oncology Fellowship Program, The University of South Alabama/Mitchell Cancer Institute, Mobile, AL
Board Certification
- present-2015: ABIM Diplomate in Medical Oncology
- present-2015: ABIM Diplomate in Hematology
- present-2011: ABIM Diplomate in Medicine
Honors & Awards
- 2019: Travel Award for Center for Clinical and Translational Science (CCTS) Training Symposium, New Orleans
- 2019: Mentor for a Conquer Cancer Medical Student Rotation award recipient
- 2018: Mobile Bay 40 under 40
- 2015-2014: Chief Hematology-Oncology Fellow; Hematology-Oncology fellowship program, The University of Miami Leonard Miller School of Medicine/Jackson Memorial Hospital
- 2014: FLASCO travel award to 2014 Annual ASCO meeting
- 2012-2011: Chief Medical Resident; Internal medicine residency program Henry Ford Hospital/Wayne State University, Detroit, MI
- 2010-2009: Junior Resident of the year; Internal medicine residency program Henry Ford Hospital, Detroit, MI
- 2009: Intern of the month; Internal medicine residency program Henry Ford Hospital, Detroit, MI
- 2009: Selected to represent the internal medicine residency program in Doctor’s Dilemma Competition in ACP Michigan chapter, Detroit, MI
- 2006-2000: Full Scholarship to study Medicine in the University of Jordan, Amman, Jordan
Professional Societies
- American Society of Clinical Oncology